|Articles|April 15, 2003
- BioPharm International-04-01-2003
- Volume 16
- Issue 4
Commercial Production of Transgenic Crops Genetically Engineered to Produce Pharmaceuticals
Author(s)Lon Crosby
by Lon Crosby Farmers may be the pharmaceutical producers of the 21st Century. The technology exists, and practices commonly used in agriculture can be modified to meet envisioned GMPs ? and those modifications are within reach.
Advertisement
Articles in this issue
over 22 years ago
Virus Inactivation in the 1990s and into the 21st Centuryover 22 years ago
Getting Ready for Risk-Based GMPsover 22 years ago
GMP Issues: Breaking Groundover 22 years ago
Guest Editorial: Benchmarking Biotechover 22 years ago
Optimized Nutrient Additives for Fed-Batch Culturesover 22 years ago
Inside Washington: GMP Progress ReportNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress
2
Analytics, Automation, and Quality Driving the Next Era of Drug Development
3
Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis
4
